- Investing Ideas
- Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
Value score of at least 4 focused on companies with a low market cap.
4 companies
Trajan Group Holdings
Market Cap: AU$31.7m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.21
7D
-1.2%
1Y
-72.7%
Medical Developments International
Market Cap: AU$50.7m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.45
7D
15.4%
1Y
-30.8%
Botanix Pharmaceuticals
Market Cap: AU$57.4m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.021
7D
-12.5%
1Y
-87.3%
Radiopharm Theranostics
Market Cap: AU$53.2m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.015
7D
-21.1%
1Y
-31.8%